Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:02 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–20 of 20 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Placebo phone call Clear all

Conditions: Advanced Breast Cancer, Anxiety, CBD
Interventions: Cannabidiol, Placebo; Drug · Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nocturia, Daytime Sleepiness
Interventions: Armodafinil, Placebo; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Smoking Cessation
Interventions: Nicotine Patch, Telephone Counseling, Placebo, Self-Help Materials; Drug · Behavioral · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 4,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: San Diego, California

Conditions: COVID, Coronavirus Infection
Interventions: Chloroquine, Placebo oral tablet; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Social Isolation, Depression
Interventions: TERTULIAS structured dialogue peer support groups, Modified Attention Placebo Control (MAPC); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Albuquerque, New Mexico

Conditions: Eosinophilic Esophagitis
Interventions: Retrospective evaluation of endoscopy prior to study drug, Symptom Survey, Medication Compliance Phone Call, Endoscopy while on study drug, Fluticasone, Omeprazole, Placebo oral capsule; Diagnostic Test · Other · Drug
Lead sponsor: Claire Daniels; Federal
Eligibility: 6 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lower Extremity Injury
Interventions: CBPT, Education Treatment; Other
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 60 Years
Enrollment: 633 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 8
States / cities: Tampa, Florida • Indianapolis, Indiana • Baltimore, Maryland + 5 more

Conditions: COVID-19, Coronavirus, Coronavirus Infections, SARS-CoV 2
Interventions: Hydroxychloroquine - Daily Dosing, Hydroxychloroquine - Weekly Dosing, Placebo oral tablet, Monitoring Visit - Baseline, Monitoring Visit - Week 4, Monitoring Visit - Week 8, Weekly Assessment; Drug · Other · Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 75 Years
Enrollment: 624 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Chronic Pain, Back Pain, Neck Pain, Opioid Misuse
Interventions: Tizanidine, MI-Opioid Taper, Placebo, Enhanced Usual Care; Drug · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Stanford, California • Kansas City, Kansas • Boston, Massachusetts + 1 more

Conditions: Migraine Headache
Interventions: Propranolol or nadolol, Placebo control, Behavioral Migraine Management (BMM), Optimal Acute Therapy; Drug · Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 2
States / cities: Athens, Ohio • Westerville, Ohio

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Interventions: Vericiguat, Placebo; Drug
Lead sponsor: Josef Stehlik; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Discharge Planning, Emergency Medicine, Geriatrics, Patient Readmission
Interventions: ED Discharge & Medication Call, Placebo Comparator; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 2,003 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Healthy
Interventions: 0.5mg AZ-010; placebo, 1mg AZ-010, 3mg AZ-010, AZ-010 1mg, IV Granisetron 1mg, Placebo; Combination Product · Drug · Other
Lead sponsor: Nova Pneuma Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: HIV Prevention
Interventions: STARS: Sistas Talking About Real Solutions, General Health & Nutrition; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 855 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Head and Neck Cancer
Interventions: Docetaxel, Erlotinib, Placebo, Questionnaires, Phone Call, Chemotherapy; Drug · Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking Cessation
Interventions: Varenicline, Bupropion, Placebo, Counseling/Phone Calls; Drug · Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 25 Years to 70 Years
Enrollment: 641 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Advanced Cancer, Fatigue
Interventions: Methylphenidate, Nursing Telephone Intervention, Placebo, Non NTI; Drug · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2021
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Ureteral Stent Placement, Kidney Stone
Interventions: Ketorolac Trometamol 30Mg/1mL Injection, Normal saline; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Food Allergy
Interventions: Counseling, Placebo phone call; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: Up to 17 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Bipolar Disorder
Interventions: Lithium Carbonate, Placebo; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 7 Years to 17 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 11
States / cities: Washington D.C., District of Columbia • South Chicago Heights, Illinois • Psychiatry and Behavioral Sciences, 1010 N Kansas St, Wichita, Kansas + 7 more

Search by objective public record fields.

RCT of CBD for Anxiety in Advanced Breast Cancer

Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia

Telephone Counseling and the Distribution of Nicotine Patches to Smokers

Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID

Tertulias Social Isolation Women's Groups Study

EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

Improving Recovery After Orthopaedic Trauma: Cognitive-Behavioral Based Physical Therapy (CBPT)

Will Hydroxychloroquine Impede or Prevent COVID-19

CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial

Drug and Non-Drug Treatment Of Severe Migraine

The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation

Use of a Brief Phone Call After ED Discharge

Staccato® Granisetron Single Dose PK

S.T.A.R.S.: Sistas Talking About Real Solutions

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

Combining Varenicline and Bupropion for Smoking Cessation

Methylphenidate and a Nursing Telephone Intervention for Fatigue

NSAIDs Stent Study

Quality of Life in Food Allergic Families

Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.